Coronary and valvular heart surgery. Other functional disturbances following cardiac surgery
Conditions
Interventions
Intervention 1: Patients in group A received acetaminophen injection every 6 hours, and if continues pain will be administered pethedine. Intervention 2: Patients in group B if have pain will be recei
Treatment - Drugs
Patients in group A received acetaminophen injection every 6 hours, and if continues pain will be administered pethedine.
Patients in group B if have pain will be received acetaminophen injection, and if continues pain will be administered pethedine.
Patients in group C received oral acetaminophen every 6 hours, and if continues pain will be administered pethedine.
Patients in group D if have pain will be received oral acetaminophen, and if continues pain will be administered pethedine.
Sponsors
Vice Chancellor for research, Lorestan University of Medical Science
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: all patients who underwent CABG surgery with or without valve replacement; age older than 18 or less than 65 years; absence of addiction to drugs or alcohol; absence of allergy or hypersensitivity to acetaminophen or narcotics; absence of impaired kidney function (creatinine level Less than 2 milligrams per deciliter); no history of liver failure; no history of sleep apnea. Exclusion criteria: Visual analog scale score is higher than 7 after extubation; not wanting to continue cooperation?; use of narcotic drugs and sedatives during the procedure?; decreased level of consciousness of the patient during the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of pain. Timepoint: Minute 0, 20, 80 and 120 after receiving the first dose. Method of measurement: visual analog scale.;The amount of narcotic. Timepoint: 24 hours after receiving the first dose. Method of measurement: Milligrams per kilogram of body weight. | — |
Secondary
| Measure | Time frame |
|---|---|
| The best pattern of use drug on regular basis or on when necessary. Timepoint: 24 hours after receiving the first dose. Method of measurement: Visual anlog scale and milligrams per kilogram of body weight.;Nausea. Timepoint: frequency during the first 24 hours after receiving the first dose. Method of measurement: history taking from patient or nurses.;Vomiting. Timepoint: frequency during the first 24 hours after receiving the first dose. Method of measurement: history taking from patient or nurses.;Need for antiemetics. Timepoint: frequency during the first 24 hours after receiving the first dose. Method of measurement: information taken from patient's records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSajad Yarahmadi
Lorestan University Of Medical Sciences
Outcome results
None listed